Europska Unija - hrvatski - EMA (European Medicines Agency)

eurogenerics holdings b.v. - teriparatid - osteoporoza - homeostaza kalcija - qutavina is indicated in adults. liječenje osteoporoze u žena u postmenopauzi i muškaraca pri povećanom riziku od loma. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures have been demonstrated. liječenje osteoporoze, povezan sa stalnim sistemsku terapiju s glukokortikoidi, kod žena i muškaraca pod povećanim rizikom prijeloma.

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

viatris limited, damastown industrial park, mulhuddart, dublin, irska - lantan karbonat - tableta za žvakanje - 500 mg - urbroj: jedna tableta za žvakanje od 500 mg sadrži količinu lantan karbonat oktahidrata ekvivalentnu 500 mg lantana

Bosna i Hercegovina - hrvatski - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

pliva d.o.o.sarajevo - zoledronska kiselina - koncentrat za otopinu za infuziju - 4 mg/5 ml - 5 ml koncentrata za otopinu za infuziju sadrži: 4 mg zoledronske kiseline (u obliku monohidrata)

Bosna i Hercegovina - hrvatski - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

novartis ba d.o.o. - indakaterol, mometazon - prašak za inhalaciju, tvrda kapsula - 125 µg/1 kapsula+ 127,5 µg/1 kapsula - 1 tvrda kapsula, praška za inhalaciju sadrži: 150 µg indakaterola (u obliku acetata) i 160 µg mometazon furoata. jedna isporučena doza (doza koja izađe iz nastavka za usta inhalera) sadrži 125 µg indakaterola (acetata) i 127,5 µg mometazon furoata.

Europska Unija - hrvatski - EMA (European Medicines Agency)

serb sas - glucarpidase - metabolic side effects of drugs and substances - svi ostali terapeutski proizvodi - voraxaze is indicated to reduce toxic plasma methotrexate concentration in adults and children (aged 28 days and older) with delayed methotrexate elimination or at risk of methotrexate toxicity.

Europska Unija - hrvatski - EMA (European Medicines Agency)

beigene ireland ltd - zanubrutinib - waldenstrom macroglobulinemia - antineoplastična sredstva - brukinsa as monotherapy is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo-immunotherapy. brukinsa as monotherapy is indicated for the treatment of adult patients with marginal zone lymphoma (mzl) who have received at least one prior anti-cd20-based therapy. brukinsa as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukemia (cll).

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

alpen pharma gmbh, steinenfeld 3, zell am harmersbach, njemačka - tekući ekstrakt (1:1,5 &ndash 2,1) iz mješavine zlatničine zeleni, zeleni guščarskog petoprsta i zeleni poljske preslice (4,2:1,4 : 1), ekstrakcijsko otapalo: etanol 50% (v/v) - oralne kapi, otopina - urbroj: 10 ml (= 9,5 g) phytocyst oralnih kapi, otopine sadrži: 7,9 ml tekućeg ekstrakta (1 : 1,5 – 2,1) iz mješavine solidago gigantea ait. i/ili solidago canadensis l., herba (zlatničina zelen), potentilla anserina l., herba (zelen guščarskog petoprsta) i equisetum arvense l., herba (zelen poljske preslice) (4,2 : 1,4 : 1). ekstrakcijsko otapalo: etanol 50 % v/v 30 kapi jednako je 1,3 ml otopine

Europska Unija - hrvatski - EMA (European Medicines Agency)

accord healthcare s.l.u. - teriparatid - osteoporoza - homeostaza kalcija - sondelbay is indicated in adults. liječenje osteoporoze u žena u postmenopauzi i muškaraca pri povećanom riziku od loma. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures have been demonstrated. liječenje osteoporoze, povezan sa stalnim sistemsku terapiju s glukokortikoidi, kod žena i muškaraca pod povećanim rizikom prijeloma.

Europska Unija - hrvatski - EMA (European Medicines Agency)

strides pharma (cyprus) limited - teriparatid - osteoporosis; osteoporosis, postmenopausal - homeostaza kalcija - kauliv is indicated in adults. treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture (see section 5. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures has been demonstrated. treatment of osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at increased risk for fracture (see section 5.

Europska Unija - hrvatski - EMA (European Medicines Agency)

vifor fresenius medical care renal pharma france - difelikefalin - pruritus - svi ostali terapeutski proizvodi - kapruvia is indicated for the treatment of moderate-to-severe pruritus associated with chronic kidney disease in adult patients on haemodialysis (see section 5.